IP Library › Granted Patent US 12,741,073
Granted Patent B2
US 12,741,073 · App. 18/241,775 · Granted Sep 22, 2026

System and method for extracorporeal temperature control

Inventors: Marc E. Voorhees (Arvada, CO); Christopher Park (Oregonia, OH); Salvatore Privitera (Mason, OH)
Assignee: Medivance Incorporated
A61M1/369A61F7/0085A61F7/12A61M5/14A61M60/113A61M60/515A61F2007/0056A61F2007/0086A61F2007/0096A61M60/268A61M60/538A61M60/857A61M2205/3355A61M2205/3368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,741,073
App. No.
18/241,775
Granted
Sep 22, 2026
Kind
B2
Abstract

A system for extracorporeal blood temperature control includes a heat exchanger configured to cool a circulated fluid, a thermal exchange module including a first volume fluidly isolated from a second volume, a fluid pump, a blood pump, and a controller. The fluid pump can pump the circulated fluid through the heat exchanger and the first volume of the thermal exchange module. The fluid pump can establish a negative pressure within the first volume of the thermal exchange module The blood pump can pump blood through a first blood flow line, the second volume of the thermal exchange module, and a second blood flow line. The controller can cool the blood by controlling thermal exchange between the circulated fluid pumped through the first volume of the thermal exchange module and the blood pumped through the second volume of the thermal exchange module.

Claims (57)

1 . A system for extracorporeal blood temperature control, comprising:

a heat exchanger configured to cool a circulated fluid;

a thermal exchange module comprising a first volume fluidly isolated from a second volume;

a fluid pump configured to pump the circulated fluid through the heat exchanger and the first volume of the thermal exchange module, wherein operation of the fluid pump establishes a negative pressure within the first volume of the thermal exchange module;

a blood pump configured to pump blood through a first blood flow line, the second volume of the thermal exchange module, and a second blood flow line; and

a controller configured to cool the blood by controlling thermal exchange between the circulated fluid pumped through the first volume of the thermal exchange module and the blood pumped through the second volume of the thermal exchange module.

2 . The system according to claim 1 , wherein:

an inlet port of the fluid pump is fluidly interconnected to an outlet port of the first volume of the thermal exchange module,

the outlet port of the thermal exchange module is fluidly interconnected to a reservoir of the heat exchanger,

the reservoir of the heat exchanger is fluidly interconnected to an outlet port of the fluid pump, and

upon operation of the fluid pump, reservoir fluid is drawn from the reservoir of the heat exchanger through the first volume of the thermal exchange module and to the inlet port of the fluid pump.

3 . The system according to claim 1 , further comprising a fluid temperature sensor configured to sense a temperature of the circulated fluid and to provide a fluid temperature signal.

4 . The system according to claim 3 , further comprising a blood temperature sensor configured to sense a temperature of the blood pumped through the second volume of the thermal exchange module and to provide a blood temperature signal, the controller configured to utilize the blood temperature signal for use in operation of the blood pump.

5 . The system according to claim 3 , wherein the controller is configured to receive a patient temperature signal indicative of a sensed patient temperature, and to utilize the sensed patient temperature together with the fluid temperature signal to generate an output signal.

6 . The system according to claim 1 , further comprising a multi-lumen catheter configured to fluidly connect to the first blood flow line and the second blood flow line.

7 . The system according to claim 6 , wherein the multi-lumen catheter comprises:

a first port, a second port, and a third port;

a first lumen configured to fluidly interconnect to the first port and to the first blood flow line;

a second lumen configured to fluidly interconnect to the second port and to the second blood flow line; and

a third lumen configured to fluidly interconnect to the third port an optional component.

8 . The system according to claim 7 , wherein the optional component comprises a source of an optional fluid selected from the group consisting of an anticoagulant, an anti-shivering agent, a contrast media, and a cooled fluid.

9 . The system according to claim 6 , wherein the blood pump, the first blood flow line, the second blood flow line, and the multi-lumen catheter are configured to accommodate blood flow through the second volume of the thermal exchange module at a blood flow rate in a range from about 50 ml/min to about 300 ml/min.

10 . The system according to claim 9 , wherein the system is configured to accommodate fluid flow through the first volume of the thermal exchange module at a fluid flow rate about five times greater than the blood flow rate.

11 . The system according to claim 9 , wherein the thermal exchange module includes a heat exchange performance factor N>0.8 across the range of the blood flow rate, wherein:

N

=

T

b

⁢

o

-

T

bi

T

cfi

-

T

bi

;

and,

T bo =temperature of blood flowing out of thermal exchange module;

T bi =temperature of blood flowing in to thermal exchange module; and,

T cfi =temperature of circulated fluid flowing in to thermal exchange module.

12 . The system according to claim 1 , wherein the controller comprises a programmable processor control module for storing control data in relation to a plurality of different temperature control phases during which a temperature of the circulated fluid is controlled differently, wherein the programmable processor control module comprises control logic for utilizing the control data to provide output signals.

13 . The system according to claim 12 , wherein the heat exchanger is further configured to warm the circulated fluid, and wherein the control data comprises:

cooling control data for use by the control logic in providing the output signals to the heat exchanger to cool the blood in at least one of the plurality of different temperature control phases; and

warming control data for use by the control logic in providing the output signals to the heat exchanger to warm the blood in at least another of the plurality of different temperature control phases.

14 . The system according to claim 12 , further comprising a user interface for receiving user input and providing user control signals, wherein the control logic utilizes the user control signals together with the control data to provide the output signals.

15 . The system according to claim 14 , wherein the user interface is employable to modify the control data stored by the programmable processor control module.

16 . The system according to claim 14 , wherein the user interface includes a graphic display to visually present a plot of a target patient temperature adjustment rate based on stored control data.

17 . The system according to claim 16 , wherein the graphic display is operable to display a plot of a sensed patient temperature in corresponding time relation to the plot of the target patient temperature adjustment rate.

18 . The system according to claim 17 , wherein the graphic display is operable to display a plot of a sensed temperature of the circulated fluid and a sensed temperature of the blood pumped through the second volume of the thermal exchange module in corresponding time relation to the plot of the target patient temperature adjustment rate.

19 . The system according to claim 14 , wherein the programmable processor control module is operable to store at least two protocols comprising corresponding, different control data, and wherein the user interface is employable by a user to select either of the at least two protocols for use by the programmable processor control module in generating the user control signals.

20 . The system according to claim 12 , wherein the control data for a first phase of the plurality of different temperature control phases comprises at least one of a target patient temperature and a target blood temperature.

21 . The system according to claim 20 , wherein the control data for the first phase of the plurality of different temperature control phases further comprises a duration measure.

22 . The system according to claim 20 , wherein the control data for a second phase of the plurality of different temperature control phases comprises a duration measure and at least one of the target patient temperature and the target blood temperature.

23 . The system according to claim 22 , wherein the control data for a third phase of the plurality of different temperature control phases comprises at least one of the target patient temperature and the target blood temperature.

Continuity (4)
Continuation 16597376 · Oct 9, 2019
Continuation 15329204 · Aug 5, 2015
Provisional Application 62037437 · Aug 14, 2014
Related Publication 20230405205A1 · Dec 21, 2023
References Cited (400)
US 3064649A · Fuson · 1962 [cited by applicant]
US 3830676A · Elkins · 1974 [cited by applicant]
US 3846518A · McPhee · 1974 [cited by applicant]
US 3944261A · Reed et al. · 1976 [cited by applicant]
US 4149541A · Gammons et al. · 1979 [cited by applicant]
US 4181132A · Parks · 1980 [cited by applicant]
US 4231425A · Engstrom · 1980 [cited by applicant]
US 4256692A · Cover · 1981 [cited by applicant]
US 4298006A · Parks · 1981 [cited by applicant]
US 4416280A · Carpenter et al. · 1983 [cited by applicant]
US 4459468A · Bailey · 1984 [cited by applicant]
US 4476867A · Parks · 1984 [cited by applicant]
US 4497324A · Sullivan et al. · 1985 [cited by applicant]
US 4596571A · Bellotti et al. · 1986 [cited by applicant]
US 4844072A · French et al. · 1989 [cited by applicant]
US 4894164A · Polaschegg · 1990 [cited by applicant]
US 4901734A · Griffin et al. · 1990 [cited by applicant]
US 4961422A · Marchosky et al. · 1990 [cited by applicant]
US D319312S · Schneider · 1991 [cited by applicant]
US 5086771A · Molloy · 1992 [cited by applicant]
US 5097829A · Quisenberry · 1992 [cited by applicant]
US 5195531A · Bennett · 1993 [cited by applicant]
US 5241951A · Mason et al. · 1993 [cited by applicant]
US 5266778A · Bailey · 1993 [cited by applicant]
US 5378230A · Mahurkar · 1995 [cited by applicant]
US 5383919A · Kelly et al. · 1995 [cited by applicant]
US 5385529A · Koch · 1995 [cited by applicant]
US 5411541A · Bell et al. · 1995 [cited by applicant]
US 5464042A · Haunhorst · 1995 [cited by applicant]
US 5472417A · Martin et al. · 1995 [cited by applicant]
US 5494074A · Ramacier, Jr. et al. · 1996 [cited by applicant]
US 5496357A · Jensen et al. · 1996 [cited by applicant]
US 5542916A · Hirsch et al. · 1996 [cited by applicant]
US 5568946A · Jackowski · 1996 [cited by applicant]
US 5591220A · Mahawili · 1997 [cited by applicant]
US 5609620A · Daily · 1997 [cited by applicant]
US 5626129A · Klimm et al. · 1997 [cited by applicant]
US 5713941A · Robins et al. · 1998 [cited by applicant]
US 5730720A · Sites · 1998 [cited by examiner]
US 5733319A · Neilson et al. · 1998 [cited by applicant]
US 5785716A · Bayron et al. · 1998 [cited by applicant]
US 5845943A · Ramacier, Jr. et al. · 1998 [cited by applicant]
US 5862803A · Besson et al. · 1999 [cited by applicant]
US 5868433A · Matkovich · 1999 [cited by applicant]
US 5871526A · Gibbs et al. · 1999 [cited by applicant]
US 5881410A · Yamada · 1999 [cited by applicant]
US 5897142A · Kulevsky · 1999 [cited by applicant]
US 5928273A · Schmidt · 1999 [cited by applicant]
US 5948012A · Mahaffey et al. · 1999 [cited by applicant]
US 6125636A · Taylor et al. · 2000 [cited by applicant]
US 6141572A · Haas · 2000 [cited by applicant]
US 6149670A · Worthen et al. · 2000 [cited by applicant]
US 6149674A · Borders · 2000 [cited by applicant]
US 6188930B1 · Carson · 2001 [cited by applicant]
US 6197045B1 · Carson · 2001 [cited by applicant]
US 6198394B1 · Jacobsen et al. · 2001 [cited by applicant]
US 6231594B1 · Dae · 2001 [cited by applicant]
US 6238354B1 · Alvarez · 2001 [cited by applicant]
US 6290717B1 · Philips · 2001 [cited by applicant]
US 6375674B1 · Carson · 2002 [cited by applicant]
US 6432124B1 · Worthen et al. · 2002 [cited by applicant]
US 6436130B1 · Philips et al. · 2002 [cited by applicant]
US 6454792B1 · Noda et al. · 2002 [cited by applicant]
US 6454793B1 · Evans et al. · 2002 [cited by applicant]
US 6461379B1 · Carson et al. · 2002 [cited by applicant]
US 6500200B1 · Kushnir · 2002 [cited by applicant]
US 6517510B1 · Stewart et al. · 2003 [cited by applicant]
US 6520933B1 · Evans et al. · 2003 [cited by applicant]
US 6551348B1 · Blalock et al. · 2003 [cited by applicant]
US 6582457B2 · Dae et al. · 2003 [cited by applicant]
US 6592612B1 · Samson et al. · 2003 [cited by applicant]
US 6609732B1 · Souvatzidis et al. · 2003 [cited by applicant]
US 6620187B2 · Carson et al. · 2003 [cited by applicant]
US 6620188B1 · Ginsburg et al. · 2003 [cited by applicant]
US 6620189B1 · Machold et al. · 2003 [cited by applicant]
US 6645232B2 · Carson · 2003 [cited by applicant]
US 6648905B2 · Hoglund et al. · 2003 [cited by applicant]
US 6660027B2 · Gruszecki et al. · 2003 [cited by applicant]
US 6669715B2 · Hoglund et al. · 2003 [cited by applicant]
US 6682551B1 · Worthen et al. · 2004 [cited by applicant]
US 6692285B2 · Islam · 2004 [cited by applicant]
US 6692518B2 · Carson · 2004 [cited by applicant]
US 6699267B2 · Voorhees et al. · 2004 [cited by applicant]
US 6702839B1 · Dae et al. · 2004 [cited by applicant]
US 6726710B2 · Worthen et al. · 2004 [cited by applicant]
US 6799063B2 · Carson · 2004 [cited by applicant]
US 6802855B2 · Ellingboe et al. · 2004 [cited by applicant]
US 6818012B2 · Ellingboe · 2004 [cited by applicant]
US 6827728B2 · Ellingboe et al. · 2004 [cited by applicant]
US 6827898B1 · Fausset et al. · 2004 [cited by applicant]
US 6871878B2 · Miros · 2005 [cited by applicant]
US 6887263B2 · Bleam et al. · 2005 [cited by applicant]
US 6921198B2 · Gruszecki et al. · 2005 [cited by applicant]
US 7008444B2 · Dae et al. · 2006 [cited by applicant]
US 7077858B2 · Fletcher et al. · 2006 [cited by applicant]
US 7089995B2 · Koscheyev et al. · 2006 [cited by applicant]
US 7179279B2 · Radons et al. · 2007 [cited by applicant]
US 7198093B1 · Elkins · 2007 [cited by applicant]
US 7207986B2 · Abboud et al. · 2007 [cited by applicant]
US 7211104B2 · Edelman · 2007 [cited by applicant]
US 7241307B2 · Lennox · 2007 [cited by applicant]
US 7294112B1 · Dunlop · 2007 [cited by applicant]
US 7361186B2 · Voorhees et al. · 2008 [cited by applicant]
US 7434842B2 · Schmidt · 2008 [cited by applicant]
US D595845S · Mros et al. · 2009 [cited by applicant]
US D601248S · Mros et al. · 2009 [cited by applicant]
US 7666213B2 · Freedman, Jr. et al. · 2010 [cited by applicant]
US 7704220B2 · Solar et al. · 2010 [cited by applicant]
US 7827815B2 · Carson et al. · 2010 [cited by applicant]
US 7867266B2 · Collins · 2011 [cited by applicant]
US 7914563B2 · Mason et al. · 2011 [cited by applicant]
US 8047010B2 · Carson et al. · 2011 [cited by applicant]
US D652510S · Lombardi, III et al. · 2012 [cited by applicant]
US 8092415B2 · Moehle et al. · 2012 [cited by applicant]
US 8182520B2 · Schock et al. · 2012 [cited by applicant]
US 8221389B2 · Brenner et al. · 2012 [cited by applicant]
US 8449589B1 · Harsy · 2013 [cited by applicant]
US 8539948B2 · Ionascu et al. · 2013 [cited by applicant]
US 8596688B2 · Pisula, Jr. et al. · 2013 [cited by applicant]
US 8597217B2 · Lowe et al. · 2013 [cited by applicant]
US 8622980B2 · Zinn · 2014 [cited by applicant]
US 8647374B2 · Koewler · 2014 [cited by applicant]
US 8663106B2 · Stivoric et al. · 2014 [cited by applicant]
US 8683996B2 · Allen et al. · 2014 [cited by applicant]
US 8808344B2 · Scott et al. · 2014 [cited by applicant]
US 8911485B2 · Brian, III et al. · 2014 [cited by applicant]
US D730518S · Lombardi, III et al. · 2015 [cited by applicant]
US 9119705B2 · Parish et al. · 2015 [cited by applicant]
US 9278024B2 · Scott et al. · 2016 [cited by applicant]
US 9283109B2 · Guyuron et al. · 2016 [cited by applicant]
US 9314367B2 · Callister et al. · 2016 [cited by applicant]
US D757259S · Duck et al. · 2016 [cited by applicant]
US 9402763B2 · Bledsoe · 2016 [cited by applicant]
US 9439803B2 · Varga et al. · 2016 [cited by applicant]
US 9566185B2 · Carson et al. · 2017 [cited by applicant]
US 9763823B2 · Voorhees et al. · 2017 [cited by applicant]
US 9918502B2 · Oliver et al. · 2018 [cited by applicant]
US 10123902B2 · Carson et al. · 2018 [cited by applicant]
US 10390992B2 · Hopper et al. · 2019 [cited by applicant]
US 10441707B2 · Voorhees · 2019 [cited by examiner]
US 10471247B2 · Kellner et al. · 2019 [cited by applicant]
US 10588779B2 · Voorhees et al. · 2020 [cited by applicant]
US 10632321B2 · Schwarz et al. · 2020 [cited by applicant]
US 10677688B2 · Rivas et al. · 2020 [cited by applicant]
US 11013635B2 · Schirrmacher et al. · 2021 [cited by applicant]
US 11039952B2 · Paxman et al. · 2021 [cited by applicant]
US 11058572B2 · Kostic et al. · 2021 [cited by applicant]
US 11285039B2 · Steele et al. · 2022 [cited by applicant]
US 11311414B2 · Scott et al. · 2022 [cited by applicant]
US 12109146B1 · Stefanoff · 2024 [cited by applicant]
US 12340881B2 · Kramb et al. · 2025 [cited by applicant]
US 20020058974A1 · Van Duren et al. · 2002 [cited by applicant]
US 20020091308A1 · Kipshidze et al. · 2002 [cited by applicant]
US 20020096311A1 · Kushnir et al. · 2002 [cited by applicant]
US 20020165590A1 · Crowe et al. · 2002 [cited by applicant]
US 20030078639A1 · Carson · 2003 [cited by applicant]
US 20030092975A1 · Casscells et al. · 2003 [cited by applicant]
US 20030163183A1 · Carson · 2003 [cited by applicant]
US 20040030373A1 · Ellingboe et al. · 2004 [cited by applicant]
US 20040059212A1 · Abreu · 2004 [cited by applicant]
US 20040064169A1 · Briscoe et al. · 2004 [cited by applicant]
US 20040073280A1 · Dae et al. · 2004 [cited by applicant]
US 20040087606A1 · Voorhees et al. · 2004 [cited by applicant]
US 20040122559A1 · Young et al. · 2004 [cited by applicant]
US 20040143170A1 · DuRousseau · 2004 [cited by applicant]
US 20040170409A1 · Faries et al. · 2004 [cited by applicant]
US 20040210166A1 · Soh et al. · 2004 [cited by applicant]
US 20040225341A1 · Schock et al. · 2004 [cited by applicant]
US 20050020958A1 · Paolini et al. · 2005 [cited by applicant]
US 20050065583A1 · Voorhees et al. · 2005 [cited by applicant]
US 20050143797A1 · Parish et al. · 2005 [cited by applicant]
US 20050177212A1 · Njemanze · 2005 [cited by applicant]
US 20050234532A1 · Eggers et al. · 2005 [cited by applicant]
US 20060069418A1 · Schock et al. · 2006 [cited by applicant]
US 20060122673A1 · Callister et al. · 2006 [cited by applicant]
US 20060177343A1 · Brian et al. · 2006 [cited by applicant]
US 20060190062A1 · Worthen · 2006 [cited by applicant]
US 20060190066A1 · Worthen · 2006 [cited by applicant]
US 20060260699A1 · Edelman et al. · 2006 [cited by applicant]
US 20060293732A1 · Collins et al. · 2006 [cited by applicant]
US 20060293734A1 · Scott et al. · 2006 [cited by applicant]
US 20070063850A1 · Devaul et al. · 2007 [cited by applicant]
US 20070118054A1 · Pinhas et al. · 2007 [cited by applicant]
US 20070118194A1 · Mason et al. · 2007 [cited by applicant]
US 20070129622A1 · Bourget et al. · 2007 [cited by applicant]
US 20070173705A1 · Teller et al. · 2007 [cited by applicant]
US 20070173735A1 · Callister et al. · 2007 [cited by applicant]
US 20070191918A1 · MacHold et al. · 2007 [cited by applicant]
US 20070213793A1 · Hayes · 2007 [cited by applicant]
US 20070236012A1 · Kerin et al. · 2007 [cited by applicant]
US 20080071150A1 · Miesel et al. · 2008 [cited by applicant]
US 20080167535A1 · Stivoric et al. · 2008 [cited by applicant]
US 20080255637A1 · Oishi · 2008 [cited by applicant]
US 20080307822A1 · Richardson · 2008 [cited by applicant]
US 20090018504A1 · Pile-Spellman et al. · 2009 [cited by applicant]
US 20090018626A1 · Levinson et al. · 2009 [cited by applicant]
US 20090018627A1 · Levinson et al. · 2009 [cited by applicant]
US 20090033333A1 · Gribova et al. · 2009 [cited by applicant]
US 20090093748A1 · Patterson et al. · 2009 [cited by applicant]
US 20090099629A1 · Carson et al. · 2009 [cited by applicant]
US 20090112298A1 · Jusiak et al. · 2009 [cited by applicant]
US 20090131835A1 · Voorhees et al. · 2009 [cited by applicant]
US 20090149779A1 · Russo et al. · 2009 [cited by applicant]
US 20090182400A1 · Dae et al. · 2009 [cited by applicant]
US 20090237264A1 · Bobey et al. · 2009 [cited by applicant]
US 20090312676A1 · Rousso et al. · 2009 [cited by applicant]
US 20090312823A1 · Patience et al. · 2009 [cited by applicant]
US 20100087900A1 · Flint · 2010 [cited by applicant]
US 20100100090A1 · Rose · 2010 [cited by applicant]
US 20100152822A1 · Callister et al. · 2010 [cited by applicant]
US 20100191165A1 · Appling et al. · 2010 [cited by applicant]
US 20100204765A1 · Hall et al. · 2010 [cited by applicant]
US 20110046693A1 · Lee et al. · 2011 [cited by applicant]
US 20110061838A1 · Richardson · 2011 [cited by applicant]
US 20110152982A1 · Richardson · 2011 [cited by applicant]
US 20110166884A1 · Lesselroth et al. · 2011 [cited by applicant]
US 20110238050A1 · Allison et al. · 2011 [cited by applicant]
US 20110319754A1 · Solar · 2011 [cited by examiner]
US 20120029408A1 · Beaudin · 2012 [cited by applicant]
US 20120095536A1 · Machold et al. · 2012 [cited by applicant]
US 20130046366A1 · Ross, III et al. · 2013 [cited by applicant]
US 20130116758A1 · Levinson et al. · 2013 [cited by applicant]
US 20130138185A1 · Paxman et al. · 2013 [cited by applicant]
US 20130238042A1 · Gildersleeve et al. · 2013 [cited by applicant]
US 20130324964A1 · Florescu · 2013 [cited by applicant]
US 20140046411A1 · Elkins et al. · 2014 [cited by applicant]
US 20140094881A1 · Dabrowiak et al. · 2014 [cited by applicant]
US 20140172050A1 · Dabrowiak · 2014 [cited by applicant]
US 20140249466A1 · Hakim · 2014 [cited by applicant]
US 20140343639A1 · Hopper et al. · 2014 [cited by applicant]
US 20150018667A1 · Radman et al. · 2015 [cited by applicant]
US 20150025411A1 · Callister et al. · 2015 [cited by applicant]
US 20150051673A1 · Rivas Tapia · 2015 [cited by applicant]
US 20150223972A1 · Dabrowiak · 2015 [cited by applicant]
US 20150230973A1 · Dabrowiak et al. · 2015 [cited by applicant]
US 20150250643A1 · Paradis · 2015 [cited by applicant]
US 20150335467A1 · Varga et al. · 2015 [cited by applicant]
US 20150335468A1 · Rose et al. · 2015 [cited by applicant]
US 20160022477A1 · Schaefer et al. · 2016 [cited by applicant]
US 20160058613A1 · Palazzolo et al. · 2016 [cited by applicant]
US 20160287433A1 · Mazzone · 2016 [cited by applicant]
US 20160361196A1 · Spence et al. · 2016 [cited by applicant]
US 20170049618A1 · Ward et al. · 2017 [cited by applicant]
US 20170071783A1 · Calderon · 2017 [cited by applicant]
US 20170135855A1 · Stefan et al. · 2017 [cited by applicant]
US 20170151087A1 · Carson et al. · 2017 [cited by applicant]
US 20170224528A1 · Berg et al. · 2017 [cited by applicant]
US 20170224529A1 · Berg et al. · 2017 [cited by applicant]
US 20170246029A1 · Clark · 2017 [cited by applicant]
US 20170246374A1 · Voorhees et al. · 2017 [cited by applicant]
US 20170259035A1 · Smith et al. · 2017 [cited by applicant]
US 20170348144A1 · Taylor et al. · 2017 [cited by applicant]
US 20170348145A1 · Voorhees et al. · 2017 [cited by applicant]
US 20170354534A1 · Paradis et al. · 2017 [cited by applicant]
US 20180042762A1 · Galer · 2018 [cited by applicant]
US 20180140459A1 · Taylor et al. · 2018 [cited by applicant]
US 20180147086A1 · Evans et al. · 2018 [cited by applicant]
US 20180163907A1 · Brugger et al. · 2018 [cited by applicant]
US 20180207024A1 · Dabrowiak et al. · 2018 [cited by applicant]
US 20180214302A1 · Dabrowiak et al. · 2018 [cited by applicant]
US 20180264222A1 · Dantanarayana et al. · 2018 [cited by applicant]
US 20190073632A1 · Laster et al. · 2019 [cited by applicant]
US 20190117446A1 · Carson et al. · 2019 [cited by applicant]
US 20190192337A1 · Taylor et al. · 2019 [cited by applicant]
US 20190223409A1 · Godfrey · 2019 [cited by applicant]
US 20190262169A1 · Vergara et al. · 2019 [cited by applicant]
US 20200000252A1 · Wang · 2020 [cited by applicant]
US 20200086033A1 · Voorhees et al. · 2020 [cited by applicant]
US 20200129325A1 · Sinha et al. · 2020 [cited by applicant]
US 20200158275A1 · Whitney, Jr. et al. · 2020 [cited by applicant]
US 20200214880A1 · Voorhees et al. · 2020 [cited by applicant]
US 20200246180A1 · Liang et al. · 2020 [cited by applicant]
US 20200261261A1 · Hopper et al. · 2020 [cited by applicant]
US 20200275859A1 · Srinivasan · 2020 [cited by applicant]
US 20200282197A1 · Anger et al. · 2020 [cited by applicant]
US 20200289361A1 · Tian et al. · 2020 [cited by applicant]
US 20200345538A1 · Carson et al. · 2020 [cited by applicant]
US 20200352781A1 · Yang · 2020 [cited by applicant]
US 20200383825A1 · Diller et al. · 2020 [cited by applicant]
US 20210022914A1 · Badawi et al. · 2021 [cited by applicant]
US 20210059854A1 · Yazawa et al. · 2021 [cited by applicant]
US 20210060230A1 · Hopper et al. · 2021 [cited by applicant]
US 20240082050A1 · Johnston et al. · 2024 [cited by applicant]
US 20240148952A1 · Hoglund et al. · 2024 [cited by applicant]
US 20240173165A1 · Smith et al. · 2024 [cited by applicant]
US 20250127655A1 · Mckinnon et al. · 2025 [cited by applicant]
US 20250161106A1 · Johnston et al. · 2025 [cited by applicant]
US 20250177196A1 · Bartolovitch et al. · 2025 [cited by applicant]
AU 2007201161B2 · 2010 [cited by applicant]
CA 2882654C · 2017 [cited by applicant]
CN 111643256A · 2020 [cited by applicant]
CN 114712091A · 2022 [cited by applicant]
DE 2851602A1 · 1980 [cited by applicant]
DE 19531935A1 · 1997 [cited by applicant]
EP 0322225A2 · 1989 [cited by applicant]
EP 0757907A1 · 1997 [cited by applicant]
EP 0846440A2 · 1998 [cited by applicant]
EP 1059903B1 · 2004 [cited by applicant]
EP 2269527A1 · 2011 [cited by applicant]
EP 2471574A1 · 2012 [cited by applicant]
GB 1604955A · 1981 [cited by applicant]
GB 2350566A · 2000 [cited by applicant]
JP 2005518837A · 2005 [cited by applicant]
JP 2008528129A · 2008 [cited by applicant]
JP 2011500174A · 2011 [cited by applicant]
WO 9636950A1 · 1996 [cited by applicant]
WO 9706840A1 · 1997 [cited by applicant]
WO 03030790A1 · 2003 [cited by applicant]
WO 03066137A1 · 2003 [cited by applicant]
WO 03071999A1 · 2003 [cited by applicant]
WO 2005117546A2 · 2005 [cited by applicant]
WO 2006034877A1 · 2006 [cited by applicant]
WO 2006081288A2 · 2006 [cited by applicant]
WO 2007121480A2 · 2007 [cited by applicant]
WO 2009049297A1 · 2009 [cited by applicant]
WO 2013102056A1 · 2013 [cited by applicant]
WO 2014189941A1 · 2014 [cited by applicant]
WO 2017035341A1 · 2017 [cited by applicant]
WO 2017172837A1 · 2017 [cited by applicant]
WO 2019133232A1 · 2019 [cited by applicant]
WO 2021139913A1 · 2021 [cited by applicant]
WO 2021242892A1 · 2021 [cited by applicant]
WO 2022164906A1 · 2022 [cited by applicant]
WO 2022192282A1 · 2022 [cited by applicant]
WO 2022197858A1 · 2022 [cited by applicant]
WO 2022235695A1 · 2022 [cited by applicant]
WO 2023101677A1 · 2023 [cited by applicant]
WO 2023163714A1 · 2023 [cited by applicant]
WO 2023204796A1 · 2023 [cited by applicant]
WO 2024107208A1 · 2024 [cited by applicant]
“Hyperthermia in Cancer Treatment” - National Cancer Institute pp. 1-3 Oct. 30, 2018. [cited by applicant]
Baronzio G. et al. “A Brief Overview of Hyperthermia in Cancer Treatment”—Journal of Integrative Oncology vol. 3 Issue 1 (2014). [cited by applicant]
Bull J. “Whole Body Hyperthermia as an Anticancer Agent” CA—A Cancer Journal for Clinician vol. 32, No. 2 pp. 123-128 Mar./Apr. 1982. [cited by applicant]
Chang et al. “Laparoscopic Continuous Hyperthermic Peritoneal Perfusion” American College of Surgeons vol. 193, No. 2, Aug. 2001 pp. 225-229. [cited by applicant]
Datta, N.R. et al. “Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future”—Cancer Treatment Reviews 41 pp. 742-753 (2015). [cited by applicant]
Hildebrandt et al. “The cellular and molecular basis of hyperthermia” Critical Reviews in Oncology/Hematology 43 pp. 33-56 (2002). [cited by applicant]
Huang et al. “It's Getting Hot in Here: Targeting Cancer Stem-like Cells with Hyperthermia”—Journal of Stem Cell and Transplantation Biology Published Date: Dec. 29, 2017. [cited by applicant]
Januszewski et al. “Hyperthermia in cancer: is it coming of age?” Lancet Oncology vol. 15 pp. 565-566 May 2014. [cited by applicant]
Mallory et al. “Therapeutic hyperthermia: The old, the new, and the upcoming” Critical Reviews in Oncology/Hematology 97 (2016) pp. 56-64. [cited by applicant]
McDaniel et al. “Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia” Int Journal Hyperthermia, 2013; 29(6): pp. 501-510. [cited by applicant]
Oei et al. “Targeting therapy-resistant cancer stem cells by hyperthermia” International Journal of Hyperthermia 33:4, pp. 419-427 (2017). [cited by applicant]
PCT/US2022/019376 filed Mar. 8, 2022, Internation Search Report and Written Opinion dated Jul. 18, 2022. [cited by applicant]
PCT/US2022/020633 filed Mar. 16, 2022 International Search Report and Written Opinion dated May 23, 2022. [cited by applicant]
Szasz et al. “Local Hyperthermia in Oncology—To Choose or not to Choose?” InTech publication pp. 1-83 (2013). [cited by applicant]
Van der Zee, J. “Heating the patient: a promising approach?” Annuals of Oncology 13 pp. 1172-1184 (2002). [cited by applicant]
PCT/US2022/050498 filed Nov. 18, 2022 International Search Report and Written Opinion dated Jun. 20, 2023. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Board Decision dated Mar. 21, 2025. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Non-Final Office Action dated May 30, 2025. [cited by applicant]
U.S. Appl. No. 17/922,584, filed Oct. 31, 2022 Non-Final Office Action dated Apr. 23, 2025. [cited by applicant]
U.S. Appl. No. 17/923,813, filed Nov. 7, 2022 Restriction Requirement dated Mar. 11, 2025. [cited by applicant]
U.S. Appl. No. 17/922,584, filed Oct. 31, 2022 Advisory Action dated Oct. 7, 2025. [cited by applicant]
U.S. Appl. No. 17/922,584, filed Oct. 31, 2022 Final Office Action dated Aug. 5, 2025. [cited by applicant]
U.S. Appl. No. 17/923,813, filed Nov. 7, 2022 Non-Final Office Action dated Jul. 1, 2025. [cited by applicant]
U.S. Appl. No. 18/280,176, filed Sep. 1, 2023 Restriction Requirement dated Aug. 25, 2025. [cited by applicant]
U.S. Appl. No. 18/282,748, filed Sep. 18, 2023 Non-Final Office Action dated Sep. 4, 2025. [cited by applicant]
PCT/US2021/061642 filed Dec. 2, 2021 Interantional Search Report and Written Opinion dated Sep. 16, 2022. [cited by applicant]
Baldwin B.A. et al: “Autonomic thermoregulatory effects of electrical stimulation of the hypothalamus in the sheet (Ovis aries)”, Journal of Thermal Biology, Pergamon Press, Oxford, GB, vol. 9, No. 4, Oct. 1, 1984, pp. … [cited by applicant]
Bard Access Systems, Inc., Additional Instructions for Use of Power-Trialysis* Aphacurve* Short-Term Dialysis Catheter, Apr. 2012, C.R. Bard Inc., Salt Lake City, Utah. [cited by applicant]
Bard Access Systems, Inc., Flow Performance Guidelines for Bard Access Systems Power-Trialysis* Alphacurve* Short-Term Dialysis Catheter, Apr. 2012, C.R. Bard Inc., Salt Lake City, Utah. [cited by applicant]
Bard Access Systems, Inc., Power-Trialysis* Short-Term Dialysis Catheter Overview and Features, www.bardaccess.com/dial-power-trialysis.php, May 19, 2014, C.R. Bard Inc., Salt Lake City, Utah. [cited by applicant]
Bard Access Systems, Inc., Short-Term Dialysis Catheter Instructions for Use, Power-Trialysis Short-Term Dialysis Catheter, Mar. 2009, C.R. Bard Inc., Salt Lake City, Utah. [cited by applicant]
Christoph Testori, et al., Rapid Induction of Mild Therapeutic Hypothermia by Extracorporeal Veno-Venous Blood Cooling in Humans, Resuscitation, 2013, vol. 84, pp. 1051-1055, Elsevier Ireland Ltd. [cited by applicant]
Michael Sung, et al., Shiver Motion and Core Body Temperature Classification for Wearable Soldier Health Monitoring Systems, MIT Media Laboratory, Human Dynamics Group, 4 Pages. Nov. 2004. [cited by applicant]
PCT/US2021/031837 filed May 11, 2021 International Search Report and Written Opinion dated Aug. 30, 2021. [cited by applicant]
PCT/US2021/034308 filed May 26, 2021 International Search Report and Written Opinion dated Aug. 26, 2021. [cited by applicant]
PCT/US2022/027508 filed May 3, 2022 International Search Report and Written Opinion dated Sep. 29, 2022. [cited by applicant]
PCTUS2022013904 filed Jan. 26, 2022 International Search Report and Written Opinion dated Apr. 21, 2022. [cited by applicant]
Stuart D.G. et al: “Activation and suppression of shivering during septal and hypothalamic stimulation”, Experimental Neurology, Elsevier, Amsterdam, NL, vol. 4, No. 6, Dec. 1, 1961, pp. 485-506. [cited by applicant]
UCSF Department of Radiology & Biomedical Imaging, Vascular Access and use of Central Lines and Ports in Adults, https://radiology.ucsf.edu/patient-care/patient-safety/contrast/iodinated- /vascular-access-adults, May 15… [cited by applicant]
U.S. Appl. No. 16/189,055, filed Nov. 13, 2018 Corrected Notice of Allowance dated May 12, 2020. [cited by applicant]
U.S. Appl. No. 16/189,055, filed Nov. 13, 2018 Notice of Allowance dated Mar. 13, 2020. [cited by applicant]
U.S. Appl. No. 16/597,376, filed Oct. 9, 2019 Non-Final Office Action dated Dec. 28, 2022. [cited by applicant]
U.S. Appl. No. 16/597,376, filed Oct. 9, 2019 Notice of Allowance dated Apr. 24, 2023. [cited by applicant]
U.S. Appl. No. 16/597,376, filed Oct. 9, 2019 Restriction Requirement dated Sep. 27, 2022. [cited by applicant]
U.S. Appl. No. 16/820,328, filed Mar. 16, 2020 Notice of Allowance datd May 18, 2022. [cited by applicant]
U.S. Appl. No. 16/933,710, filed Jul. 20, 2020 Notice of Allowance dated Feb. 23, 2023. [cited by applicant]
U.S. Appl. No. 17/313,771, filed May 6, 2021 Non-Final Office Action dated Aug. 24, 2021. [cited by applicant]
U.S. Appl. No. 17/313,771, filed May 6, 2021 Notice of Allowance dated Jan. 18, 2022. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Examiner's Answer dated Aug. 2, 2023. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Final Office Action dated Oct. 20, 2022. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Non-Final Office Action dated Jul. 6, 2022. [cited by applicant]
Hirchika Imoto et al., “Use of a Peltier chip with a newly devised local brain-cooling system for neocortical seizures in the rat”, J Neurosurg 104:150-156, 2006. [cited by applicant]
Natalia Mejia et al., “An On-Site Thermoelectric Cooling Device for Cryotherapy and Control of Skin Blood Flow”, Journal of Medical Devices vol. 9, pp. 044502-1 to 044502-6, Dec. 2015. [cited by applicant]
PCT/US2022/018008 filed Feb. 25, 2022 International Search Report and Written Opinion dated Oct. 4, 2022. [cited by applicant]
PCT/US2022/025222 filed Apr. 18, 2022 International Search Report and Written Opinion dated Jan. 30, 2023. [cited by applicant]
Shahriar Ahmed et al., “Development of a Cooling Unit for the Emergency Treatment of Head Injury”, IFMBE, vol. 14, SpringerLink Conference paper pp. 3243-3246, World Congress on Medical Physics and Biomedical Engineerin… [cited by applicant]
Tauchi et al., “Targeted Temperature Management: Peltier's Element-Based Focal Brain Cooling Protects Penumbra Neurons from Progressive Damage in Experimental Cerebral Ischemia”, Therapeutic Hypothermia and Temperature … [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Advisory Action dated Mar. 5, 2026. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Final Office Action dated Dec. 5, 2025. [cited by applicant]
U.S. Appl. No. 17/922,584, filed Oct. 31, 2022 Non-Final Office Action dated Nov. 4, 2025. [cited by applicant]
U.S. Appl. No. 17/923,813, filed Nov. 7, 2022 Advisory Action dated Mar. 2, 2026. [cited by applicant]
U.S. Appl. No. 17/923,813, filed Nov. 7, 2022 Final Office Action dated Dec. 29, 2025. [cited by applicant]
U.S. Appl. No. 18/274,415, filed Jul. 26, 2023 Non-Final Office Action dated Feb. 24, 2026. [cited by applicant]
U.S. Appl. No. 18/274,415, filed Jul. 26, 2023 Restriction Requirement dated Dec. 5, 2025. [cited by applicant]
U.S. Appl. No. 18/280,176, filed Sep. 1, 2023 Non-Final Office Action dated Dec. 2, 2025. [cited by applicant]
U.S. Appl. No. 18/282,748, filed Sep. 18, 2023 Final Office Action dated Jan. 22, 2026. [cited by applicant]
U.S. Appl. No. 18/715,064, filed May 30, 2024 Non-Final Office Action dated Mar. 4, 2026. [cited by applicant]
U.S. Appl. No. 17/735,984, filed May 3, 2022 Final Office Action dated Apr. 1, 2026. [cited by applicant]
U.S. Appl. No. 17/923,813, filed Nov. 7, 2022 Non-Final Office Action dated Apr. 27, 2026. [cited by applicant]
U.S. Appl. No. 18/280,176, filed Sep. 1, 2023 Final Office Action dated Apr. 7, 2026. [cited by applicant]